Article R1124-17 of the French Public Health Code
November 6, 2023
An accelerated assessment procedure may be set up under conditions defined by order of the Minister for Health when the clinical trial of medicinal products takes place in the context of an emergency situation or a serious health threat, or when it concerns the assessment of a promising compound in an indication with a severe prognosis and no therapeutic alternative. By way of derogation from the first paragraph of II…
